Abstract
We constructed gold nanoparticle-coated liposome/doxorubicin (GCL/DOX) for the purpose of combination therapy and focused on 1) controlled drug release from the thermosensitive liposomes triggered by near-infrared laser (NIR-laser) irradiation and 2) the photothermal effect of the gold nanoshell-like structures upon absorbing laser light. GCL/DOX was prepared using thiol-group-spiked liposomes containing glutathione conjugated to gold nanoparticles under reducing conditions. The absorption peak of GCL was dependent on the amount of added HAuCl4 and shifted from 636 to 795 nm, appropriate for the absorption of NIR laser light (660 nm) by GCL/DOX. Most of the encapsulated drug was released from GCL/DOX within 1 min (>80%) under NIR laser irradiation. GCL/DOX exhibited a synergistic effect compared to monotherapy (photothermal effect alone or free-DOX treatment alone) on A549 cells. GCL is thus an effective liposome carrier, and in conjunction with NIR laser irradiation its therapeutic modality holds promise for cancer treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Colloids and Surfaces A: Physicochemical and Engineering Aspects
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
